Matt is the Chief Executive Officer at Medterra Pharma and has experience in creating and running biotech start-ups around novel, cutting edge scientific advancements and plans. He is an efficient executioner, and able to be nimble and flexible as any project requires. Matt has a track record of increasing value assets and profiles quickly, and able to speak both science and business “languages.”
Matt has a history of working in the research industry. He is skilled in several wet lab techniques (e.g. Histology, PCR, western blots, ELISA, Dendritic Cells, T cells, Neutrophils, Molecular Biology, Cell Culture, animal work, etc). Matt’s foundational academic and lab experience aids in development decisions, creating more accurate timelines and milestone expectations, and setting up strong contingency plans for all primary goals.